SCHEMBL1324281

SCHEMBL1324281

O=C(C=Cc1ccc(I)cc1)NS(=O)(=O)C=Cc1ccc(I)cc1.O=S(=O)(C=Cc1ccc(I)cc1)NS(=O)(=O)C=Cc1ccc(I)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.39
HDAC4 P56524 5/20 0.39
HDAC8 Q9BY41 5/20 0.39
HDAC2 Q92769 4/20 0.39
HDAC3 O15379 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1324278 1.00 HDAC1 (0.39) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1323721 0.95 LMNA (0.40) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1323310 0.95 LMNA (0.40) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1323314 0.95 LMNA (0.40) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1323607 0.95 LMNA (0.40) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1324397 0.85 CYP1A2 (0.46) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1324399 0.85 CYP1A2 (0.46) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1324753 0.85 HDAC2 (0.53) HDAC1HDAC4HDAC8HDAC2HDAC3
SCHEMBL1324636 0.85 CA12 (0.49) LMNAKMT2AMMP1MMP2MMP9
SCHEMBL1324751 0.85 HDAC2 (0.53) HDAC1HDAC4HDAC8HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058313-B2 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases Temple University—Of the Commonwealth System of Higher Education (US) 2011-11-15 US claimed